0
Skip to Content
Purilogics
Purilogics
About
Our mission
Our Team
Careers
Ethics & Compliance
Products
Products overview
Purexa™ PrA
Purexa™ MCP
Purexa™ NAEX
Purexa™ OdT
Technology
How it works
Case Studies
Patents
News
Contact Us
Purilogics
Purilogics
About
Our mission
Our Team
Careers
Ethics & Compliance
Products
Products overview
Purexa™ PrA
Purexa™ MCP
Purexa™ NAEX
Purexa™ OdT
Technology
How it works
Case Studies
Patents
News
Contact Us
Folder: About
Back
Our mission
Our Team
Careers
Ethics & Compliance
Folder: Products
Back
Products overview
Purexa™ PrA
Purexa™ MCP
Purexa™ NAEX
Purexa™ OdT
Folder: Technology
Back
How it works
Case Studies
Patents
News
Contact Us
Purilogics Awarded Competitive Grant from the National Institute of Health
jeremy hogenbaum 6/10/19 jeremy hogenbaum 6/10/19

Purilogics Awarded Competitive Grant from the National Institute of Health

Purilogics has been awarded an NIH Small Business Innovation Research (SBIR) Phase I grant for $220,772 to commercialize novel lentiviral vector affinity membrane chromatography technology.

Read More

Contact us ⭷

215 Innovation Dr, Suite D
Greenville, SC 29607


Purilogics.Information@donaldson.com

 
 

Sitemap

Home
Technology
Contact
News
About
Our Team
Ethics & Compliance
Products

 

Products

Purexa™ Products overview
Purexa™ PrA (PDF)
Purexa™ OdT (PDF)
Purexa™ MCP (PDF)
Purexa™ NAEX Plus (PDF)

 

© 2025 by Purilogics. Our Privacy Policy, Terms and Conditions of Use,  Terms & Conditions of Sale